Potential impact of evidence-based medicine in acute coronary syndromes: insights from GUSTO-IIb
Authors:
- Karen P AlexanderKAKaren P Alexander
- Eric D PetersonEPEric D Peterson
- Christopher B GrangerCGChristopher B Granger
- A.Cecilia CasasACA.Cecilia Casas
- Frans Van de WerfFWFrans Van de Werf
- Paul W ArmstrongPAPaul W Armstrong
- Alan GuerciAGAlan Guerci
- Eric J TopolETEric J Topol
- Robert M CaliffRCRobert M Califf
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- ACC/AHA guidelines for the management of patients with acute myocardial infarctionJACC, 1996
- A Comparison of Recombinant Hirudin with Heparin for the Treatment of Acute Coronary SyndromesNew England Journal of Medicine, 1996
- NifedipineCirculation, 1995
- Quality of Care for Medicare Patients With Acute Myocardial InfarctionJAMA, 1995
- Angiotensin-converting enzyme inhibitors and calcium antagonists after acute myocardial infarctionThe American Journal of Cardiology, 1995
- Comparison of the natural history of new onset and exacerbated chronic ischemic heart diseaseJACC, 1990
- Calcium channel blockers in acute myocardial infarction and unstable angina: an overview.BMJ, 1989
- Risk of adverse outcome in patients admitted to the coronary care unit with suspected unstable angina pectorisThe American Journal of Cardiology, 1989
- The Effect of Diltiazem on Mortality and Reinfarction after Myocardial InfarctionNew England Journal of Medicine, 1988
- Nifedipine and conventional therapy for unstable angina pectoris: a randomized, double-blind comparison.Circulation, 1984